Adaptive Design: The Faster Path to Market

An adaptive design clinical trial can help to create a stronger value proposition for your medical device and give you a competitive edge, by reducing development costs and accelerating time-to-market.

Adaptive design allows for pre-set interim analyses to assess efficacy, treatment effect and other critical data, allowing you to make better, more informed development decisions.

ICON experts have more than a decade of experience in the design, simulation and execution of adaptive design trials. Our operational teams and specialised technologies enable medical device manufacturers to apply the power of adaptive design to:

• Design seamless, multistage trials that conserve patients and remove whitespace
• Prevent underpowered and overpowered studies
• Guard against unexpectedly high sham response
• Enable effective reallocation of resources through early termination for futility or efficacy